Clinical Trial Update: A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug-coated Stents and the Xience Drug-eluting Stent System in Patients With Acute Coronary Syndrome and High Bleeding Risk Using Optical Coherence Tomography [NA]

View source ↗

Summary

A clinical study evaluating vascular healing and neointimal transformation at 1 month after implantation of BioFreedom paclitaxel-coated stents and the Xience e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Coronary Syndrome

Drugs mentioned

• BioFreedom Drug-coated Stent (paclitaxel)
• Xience Drug-eluting Stent System (everolimus)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Coronary Heart Disease, Acute Coronary Syndrome | NA | Status: RECRUITING